![Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis–associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects]()
Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis–associated liver fibrosis and tumor development in mice independently of its anti-diabetic effectsKawakubo, Mitsuhiro; Tanaka, Miyako; Ochi, Kozue; Watanabe, Akiko; Saka-Tanaka, Marie; Kanamori, Yohei; Yoshioka, Naoki; Yamashita, Satoko; Goto, Moritaka; Itoh, Michiko; Shirakawa, Ibuki; Kanai, Sayaka; Suzuki, Hiromi; Sawada, Makoto; Ito, Ayaka; Ishigami, Masatoshi; Fujishiro, Mitsuhiro; Arima, Hiroshi; Ogawa, Yoshihiro; Suganami, Takayoshi · Scientific Reports · 2020